Document is current
Any future updates will be listed below
-
Authors
Hill, Lesley A. https://orcid.org/0000-0001-6609-1935
Scott, R. Wilder https://orcid.org/0000-0001-7608-7489
Martin, Lauren A.
Arostegui, Martin
Davenport, George
Vemon, Marcos
Hofvander, Jakob https://orcid.org/0000-0002-8787-1866
Wang, Xue Qi https://orcid.org/0000-0002-7249-1908
Li, Jinxiu
Nielsen, Torsten O. https://orcid.org/0000-0003-3769-2517
Jones, Kevin B. https://orcid.org/0000-0003-1531-2157
Hirst, Martin
Underhill, T. Michael https://orcid.org/0000-0003-3048-9102
-
Funding
Funding for this research was provided by:
Terry Fox Research Institute (1155)
Gouvernement du Canada | Canadian Institutes of Health Research (PT-025845)
Foundation for the National Institutes of Health (CA231652)
- License Information
-
More Information
Article History
Received: 17 December 2024
Accepted: 23 October 2025
First Online: 2 December 2025
Competing interests
: L.A.H., R.W.S. and T.M.U. are co-founders of Mesintel Therapeutics Inc., and T.M.U. is a founder of Mesentech Inc. All other authors declare no competing interests.
